Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Benzene metabolism WP3891	2/6	0.008718577527855507	1.0	0	0	13.36005344021376	63.357370499766176	NQO1;DHDH
Estrogen metabolism WP697	3/18	0.009530092468954818	1.0	0	0	6.68002672010688	31.084174071007013	SULT1A1;NQO1;CYP1A1
Hippo-Merlin Signaling Dysregulation WP4541	8/120	0.010474959804148682	1.0	0	0	2.6720106880427523	12.18107588642371	NGFR;ITGAM;ITGA2;ITGB2;ITGA1;ITGAV;PRKACA;MET
Human Complement System WP2806	7/97	0.010787498561677449	1.0	0	0	2.8923827035514327	13.100663798249917	FKBP2;CR1;ITGA2;ITGB2;WAS;SPP1;PRKACA
Integrin-mediated Cell Adhesion WP185	7/101	0.013278988006625657	1.0	0	0	2.777832893509792	12.004605803728378	ITGAM;ITGA2;ITGB2;ITGA1;CAPN3;ITGAV;MAP2K6
NAD Biosynthesis II (from tryptophan) WP2485	2/8	0.015744862472324966	1.0	0	0	10.02004008016032	41.5956027971552	AFMID;NADSYN1
Microglia Pathogen Phagocytosis Pathway WP3937	4/40	0.01721887297349511	1.0	0	0	4.008016032064129	16.27955603534299	ITGAM;NCF1;ITGB2;NCF4
TYROBP Causal Network WP3945	5/61	0.017942576223113686	1.0	0	0	3.2852590426755146	13.208642959627593	ITGAM;BIN2;ITGB2;RNASE6;SPP1
Thiamine metabolic pathways WP4297	2/9	0.019912211750142357	1.0	0	0	8.90670229347584	34.882405519263955	TPK1;TKT
Aryl Hydrocarbon Receptor WP2586	4/46	0.027380120670636623	1.0	0	0	3.485231332229677	12.539646429822215	NQO1;CYP1A1;AHRR;CD36
Arrhythmogenic Right Ventricular Cardiomyopathy WP2118	5/74	0.03747853104420887	1.0	0	0	2.7081189405838706	8.89342743713746	ITGA2;ITGA1;CACNA2D3;ITGAV;CACNA2D4
Dopamine metabolism WP2436	2/13	0.040402734490517254	1.0	0	0	6.16617851086789	19.78639007798208	NQO1;PRKACA
Osteopontin Signaling WP1434	2/13	0.040402734490517254	1.0	0	0	6.16617851086789	19.78639007798208	SPP1;ITGAV
Ebola Virus Pathway on Host WP4217	7/129	0.04305042893182533	1.0	0	0	2.1748924204999147	6.8408698302322435	GSN;ITGA2;CLTCL1;ITGA1;ITGAV;ASGR1;HLA-DPA1
H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969	2/14	0.046373648320711176	1.0	0	0	5.72573718866304	17.583875781291272	CDK8;TULP3
Fatty Acid Omega Oxidation WP206	2/15	0.05264396193280757	1.0	0	0	5.344021376085505	15.733887669292315	ALDH2;CYP1A1
Phytochemical activity on NRF2 transcriptional activation WP3	2/15	0.05264396193280757	1.0	0	0	5.344021376085505	15.733887669292315	NQO1;SLC7A11
Osteoclast Signaling WP12	2/16	0.059195084025969825	1.0	0	0	5.01002004008016	14.162909722655604	CTSK;SPP1
Tryptophan catabolism leading to NAD+ production WP4210	2/16	0.059195084025969825	1.0	0	0	5.01002004008016	14.162909722655604	AFMID;NADSYN1
Fibrin Complement Receptor 3 Signaling Pathway WP4136	3/37	0.06422834016420031	1.0	0	0	3.2497427287006446	8.921553583201426	ITGAM;IRAK2;ITGB2
Tamoxifen metabolism WP691	2/21	0.09556240546555268	1.0	0	0	3.81715812577536	8.962594845063215	SULT1A1;CYP1A1
Hedgehog Signaling Pathway WP4249	3/44	0.09661832954836673	1.0	0	0	2.7327382036800874	6.386373134138706	FBXL17;ARRB1;PRKACA
Interleukin-11 Signaling Pathway WP2332	3/44	0.09661832954836673	1.0	0	0	2.7327382036800874	6.386373134138706	IL11;FES;ITGA2
NAD+ biosynthetic pathways WP3645	2/22	0.10344757711016117	1.0	0	0	3.6436509382401168	8.266315525388785	BST1;NADSYN1
miRNA targets in ECM and membrane receptors WP2911	2/22	0.10344757711016117	1.0	0	0	3.6436509382401168	8.266315525388785	LAMB2;ITGA1
Aryl Hydrocarbon Receptor Pathway WP2873	3/46	0.10688428785249275	1.0	0	0	2.6139234991722575	5.844755036032491	NQO1;CYP1A1;AHRR
Tryptophan metabolism WP465	3/46	0.10688428785249275	1.0	0	0	2.6139234991722575	5.844755036032491	ALDH2;AFMID;CYP1A1
NRF2-ARE regulation WP4357	2/23	0.11150273046053624	1.0	0	0	3.485231332229677	7.6455735817600345	NQO1;SLC7A11
Chemokine signaling pathway WP3929	7/164	0.11695387683314273	1.0	0	0	1.7107385502712744	3.6712032501741234	CCL22;NCF1;CCL7;WAS;ARRB1;RASGRP2;CCR4
Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs) WP688	1/5	0.11868930417379521	1.0	0	0	8.016032064128257	17.084136989836733	FMO5
Secretion of Hydrochloric Acid in Parietal Cells WP2597	1/5	0.11868930417379521	1.0	0	0	8.016032064128257	17.084136989836733	HRH2
Arylamine metabolism WP694	1/6	0.14068347176921273	1.0	0	0	6.68002672010688	13.101154263168134	SULT1A1
exRNA mechanism of action and biogenesis WP2805	1/6	0.14068347176921273	1.0	0	0	6.68002672010688	13.101154263168134	XPO5
miRNA Biogenesis WP2338	1/6	0.14068347176921273	1.0	0	0	6.68002672010688	13.101154263168134	XPO5
Canonical  and Non-canonical Notch signaling WP3845	2/27	0.1451644549749239	1.0	0	0	2.9689007644919467	5.72964597939032	HEY1;DLK2
DNA IR-Double Strand Breaks (DSBs) and cellular response via ATM WP3959	3/55	0.1576985010678366	1.0	0	0	2.18619056294407	4.038047637132014	RASSF1;CHEK2;TP53BP1
Hematopoietic Stem Cell Differentiation WP2849	3/55	0.1576985010678366	1.0	0	0	2.18619056294407	4.038047637132014	NFE2;SPI1;CBFA2T3
RANKL/RANK (Receptor activator of NFKB (ligand)) Signaling Pathway WP2018	3/55	0.1576985010678366	1.0	0	0	2.18619056294407	4.038047637132014	SPI1;CTSK;MAP2K6
Disorders of the Krebs cycle WP4236	1/7	0.1621298222363275	1.0	0	0	5.72573718866304	10.417165146564741	SUCLG2
MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593	1/7	0.1621298222363275	1.0	0	0	5.72573718866304	10.417165146564741	HEY1
Pentose Phosphate Metabolism WP134	1/7	0.1621298222363275	1.0	0	0	5.72573718866304	10.417165146564741	TKT
Cannabinoid receptor signaling WP3869	2/29	0.16269376292415	1.0	0	0	2.764148987630433	5.0193783437657435	CYP1A1;PRKACA
Vitamin D Receptor Pathway WP2877	7/182	0.17092659828080414	1.0	0	0	1.5415446277169724	2.7231710566570255	CDKN2D;STEAP4;ITGAM;ALOX5;CYP1A1;SPP1;S100A8
ApoE and miR-146 in inflammation and atherosclerosis WP3926	1/8	0.18304197291732785	1.0	0	0	5.01002004008016	8.507213387954755	SPI1
Phase I biotransformations, non P450 WP136	1/8	0.18304197291732785	1.0	0	0	5.01002004008016	8.507213387954755	PON2
Oxidative Stress WP408	2/33	0.19872802219851757	1.0	0	0	2.4291006254934113	3.924984785802817	NQO1;CYP1A1
Signal transduction through IL1R WP4496	2/33	0.19872802219851757	1.0	0	0	2.4291006254934113	3.924984785802817	IRAK2;MAP2K6
Benzo(a)pyrene metabolism WP696	1/9	0.2034332036105457	1.0	0	0	4.45335114673792	7.091594592595487	CYP1A1
LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258	4/94	0.2078634121569063	1.0	0	0	1.705538737048565	2.6791866069280528	CDK8;FZD2;CSNK2A2;NKD1
Signaling of Hepatocyte Growth Factor Receptor WP313	2/34	0.20788559348521826	1.0	0	0	2.357656489449487	3.703329911410121	ITGA1;MET
Type 2 papillary renal cell carcinoma WP4241	2/34	0.20788559348521826	1.0	0	0	2.357656489449487	3.703329911410121	ARNT2;CTSK
Endochondral Ossification WP474	3/64	0.2142944279585239	1.0	0	0	1.8787575150300602	2.8940463012915596	SPP1;PRKACA;CST5
B Cell Receptor Signaling Pathway WP23	4/97	0.22362462152626242	1.0	0	0	1.6527901163151044	2.475526607198604	PTPN18;GSK3A;BTK;MAP2K6
PPAR signaling pathway WP3942	3/67	0.234041265505709	1.0	0	0	1.7946340442078186	2.6062713442233294	FADS2;CD36;SLC27A2
Melatonin metabolism and effects WP3298	2/37	0.23558328242720192	1.0	0	0	2.1664951524670966	3.132082082352866	SULT1A1;CYP1A1
Serotonin Transporter Activity WP1455	1/11	0.24270438526211566	1.0	0	0	3.6436509382401168	5.159085799816664	STX1A
Sterol Regulatory Element-Binding Proteins (SREBP) signalling WP1982	3/69	0.24738022597343726	1.0	0	0	1.7426156661148384	2.4341356618782064	CDK8;GSK3A;PRKACA
Genes related to primary cilium development (based on CRISPR) WP4536	4/103	0.25599822083675244	1.0	0	0	1.5565110804132536	2.1208783148948935	BBS12;INPP5E;WDR19;TULP3
MAPK  and NFkB Signalling Pathways Inhibited by Yersinia YopJ WP3849	1/12	0.26160928125317606	1.0	0	0	3.34001336005344	4.4786345398527265	MAP2K6
ATM Signaling Pathway WP2516	2/40	0.26346556444202246	1.0	0	0	2.0040080160320644	2.6730112320046	CHEK2;TP53BP1
Bladder Cancer WP2828	2/40	0.26346556444202246	1.0	0	0	2.0040080160320644	2.6730112320046	RASSF1;UPK3A
IL-5 Signaling Pathway WP127	2/40	0.26346556444202246	1.0	0	0	2.0040080160320644	2.6730112320046	GSK3A;BTK
Regulation of toll-like receptor signaling pathway WP1449	5/139	0.26688352910714297	1.0	0	0	1.4417323856345785	1.904446210876801	SIGIRR;IRAK2;BTK;SPP1;MAP2K6
Primary Focal Segmental Glomerulosclerosis FSGS WP2572	3/72	0.26759356518056165	1.0	0	0	1.67000668002672	2.2015464218898466	CR1;LAMB2;ITGAV
Nuclear Receptors Meta-Pathway WP2882	10/319	0.27559267119280106	1.0	0	0	1.256431358013833	1.619328101199122	SULT1A1;IL11;FGD4;NQO1;SLC6A8;CYP1A1;SLC39A11;AHRR;SLC7A11;PTGR1
Development of pulmonary dendritic cells and macrophage subsets WP3892	1/13	0.28004316287106085	1.0	0	0	3.083089255433945	3.924191566463159	SPI1
Estrogen Receptor Pathway WP2881	1/13	0.28004316287106085	1.0	0	0	3.083089255433945	3.924191566463159	CYP1A1
Genes targeted by miRNAs in adipocytes WP1992	1/13	0.28004316287106085	1.0	0	0	3.083089255433945	3.924191566463159	KCNQ1
Kennedy pathway from Sphingolipids WP3933	1/13	0.28004316287106085	1.0	0	0	3.083089255433945	3.924191566463159	CHKB
MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301	1/13	0.28004316287106085	1.0	0	0	3.083089255433945	3.924191566463159	ITGAV
ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337	1/13	0.28004316287106085	1.0	0	0	3.083089255433945	3.924191566463159	IL11
Fas Ligand (FasL) pathway and Stress induction of Heat Shock Proteins (HSP) regulation WP314	2/42	0.28206925448515735	1.0	0	0	1.90857906288768	2.4155027291038484	DFFB;FASLG
Metabolic reprogramming in colon cancer WP4290	2/42	0.28206925448515735	1.0	0	0	1.90857906288768	2.4155027291038484	SUCLG2;TKT
Vitamin A and Carotenoid Metabolism WP716	2/43	0.29135825394517834	1.0	0	0	1.864193503285641	2.2989265149749634	SULT1A1;CD36
Osteoblast Signaling WP322	1/14	0.29801774237092626	1.0	0	0	2.86286859433152	3.4657951791914905	ITGAV
NRF2 pathway WP2884	5/146	0.3005873172648354	1.0	0	0	1.372608230158948	1.649898418692762	NQO1;SLC6A8;SLC39A11;SLC7A11;PTGR1
ATM Signaling Network in Development and Disease  WP3878	2/45	0.30988425031274364	1.0	0	0	1.7813404586951682	2.0869408814372057	CHEK2;TP53BP1
Ras Signaling WP4223	6/184	0.31139427036755796	1.0	0	0	1.3069617495861288	1.524826286497194	NGFR;RASSF1;FASLG;PRKACA;RASGRP2;MET
GPCRs, Class C Metabotropic glutamate, pheromone WP501	1/15	0.31554444134617654	1.0	0	0	2.6720106880427523	3.0820460838194843	GPRC5A
Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203	2/47	0.3283089077825412	1.0	0	0	1.705538737048565	1.8996295941430157	FES;BTK
TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453	1/16	0.33263439792491434	1.0	0	0	2.50501002004008	2.757292826325945	SUCLG2
Structural Pathway of Interleukin 1 (IL-1) WP2637	2/49	0.3465972728961172	1.0	0	0	1.6359249110465828	1.7334125719038218	IRAK2;MAP2K6
Cells and Molecules involved in local acute inflammatory response  WP4493	1/17	0.3492984738086775	1.0	0	0	2.357656489449487	2.4798502804764877	ITGB2
NOTCH1 regulation of human endothelial cell calcification WP3413	1/17	0.3492984738086775	1.0	0	0	2.357656489449487	2.4798502804764877	ITGA1
Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664	1/17	0.3492984738086775	1.0	0	0	2.357656489449487	2.4798502804764877	LRP1
Sulfation Biotransformation Reaction WP692	1/17	0.3492984738086775	1.0	0	0	2.357656489449487	2.4798502804764877	SULT1A1
Viral Acute Myocarditis WP4298	3/84	0.34958922036658563	1.0	0	0	1.43143429716576	1.5044323931689507	DFFB;ITGB2;AIF1
Photodynamic therapy-induced AP-1 survival signaling. WP3611	2/50	0.35568043613445394	1.0	0	0	1.6032064128256514	1.6572707055198723	FASLG;MAP2K6
Pyrimidine metabolism WP4022	3/85	0.3564235443664473	1.0	0	0	1.4145938936696922	1.4593453126486453	POLR2J3;CDA;NME3
ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336	3/86	0.3632482347064938	1.0	0	0	1.3981451274642307	1.4158579991575921	FZD2;CSNK2A2;NKD1
Synaptic Vesicle Pathway WP2267	2/51	0.3647180697747147	1.0	0	0	1.5717709929663248	1.585336375400671	CLTCL1;STX1A
4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879	1/18	0.36554726108427393	1.0	0	0	2.22667557336896	2.2408365683798293	MAP2K6
Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670	1/18	0.36554726108427393	1.0	0	0	2.22667557336896	2.2408365683798293	NQO1
TCA Cycle (aka Krebs or citric acid cycle) WP78	1/18	0.36554726108427393	1.0	0	0	2.22667557336896	2.2408365683798293	SUCLG2
Focal Adhesion WP306	6/198	0.37330930573408727	1.0	0	0	1.2145503127467057	1.1967546791438815	LAMB2;ITGA2;ITGA1;SPP1;ITGAV;MET
Apoptosis Modulation by HSP70 WP384	1/19	0.38139108902006696	1.0	0	0	2.1094821221390148	2.033392996431885	FASLG
Extracellular vesicles in the crosstalk of cardiac cells WP4300	1/19	0.38139108902006696	1.0	0	0	2.1094821221390148	2.033392996431885	SPP1
Allograft Rejection WP2328	3/89	0.3836457319085762	1.0	0	0	1.3510166400216161	1.2943222067258568	CSNK2A2;FASLG;HLA-DPA1
Cytoplasmic Ribosomal Proteins WP477	3/89	0.3836457319085762	1.0	0	0	1.3510166400216161	1.2943222067258568	RPS28;RPL36A;RPS10
Nanomaterial induced apoptosis WP2507	1/20	0.3968400302739368	1.0	0	0	2.0040080160320644	1.8521483485228958	FASLG
Apoptosis Modulation and Signaling WP1772	3/91	0.3971624190671116	1.0	0	0	1.3213239666145478	1.220123718983501	DFFB;TNFRSF10C;FASLG
IL-1 signaling pathway WP195	2/55	0.4003486021478105	1.0	0	0	1.4574603752960467	1.3341878025796103	IRAK2;MAP2K6
Glycerophospholipid Biosynthetic Pathway WP2533	1/21	0.41190390766271523	1.0	0	0	1.90857906288768	1.6928431924118923	CHKB
Nicotine Activity on Dopaminergic Neurons WP1602	1/21	0.41190390766271523	1.0	0	0	1.90857906288768	1.6928431924118923	PRKACA
MAPK Signaling Pathway WP382	7/246	0.41618629607656243	1.0	0	0	1.1404923668475162	0.9997810324728629	CACNA2D3;FASLG;ARRB1;CACNA2D4;PRKACA;RASGRP2;MAP2K6
Preimplantation Embryo WP3527	2/58	0.4264465264050228	1.0	0	0	1.3820744938152165	1.1778982760344732	DLX2;MYBL1
Regulation of Apoptosis by Parathyroid Hormone-related Protein WP3872	1/22	0.42659230012065946	1.0	0	0	1.8218254691200584	1.5520614365461916	GSK3A
Vitamin D in inflammatory diseases WP4482	1/22	0.42659230012065946	1.0	0	0	1.8218254691200584	1.5520614365461916	MAP2K6
Estrogen signaling pathway WP712	1/23	0.4409145486177336	1.0	0	0	1.7426156661148384	1.4270352698742312	PRKACA
Hippo-Yap signaling pathway WP4537	1/23	0.4409145486177336	1.0	0	0	1.7426156661148384	1.4270352698742312	RASSF1
Nanoparticle triggered autophagic cell death WP2509	1/23	0.4409145486177336	1.0	0	0	1.7426156661148384	1.4270352698742312	ATG10
Pathways Regulating Hippo Signaling WP4540	3/98	0.44375323966298486	1.0	0	0	1.2269436832849372	0.9968753477201518	NGFR;PRKACA;MET
Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612	1/24	0.4548797623515939	1.0	0	0	1.67000668002672	1.3155012583860386	NQO1
miRNA regulation of p53 pathway in prostate cancer WP3982	1/24	0.4548797623515939	1.0	0	0	1.67000668002672	1.3155012583860386	CHEK2
Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668	1/25	0.4684968242387519	1.0	0	0	1.6032064128256514	1.2155927148684615	FBN2
Lung fibrosis WP3624	2/63	0.4685698743106791	1.0	0	0	1.27238604192512	0.9645577423859204	FAM13A;SPP1
PI3K-Akt Signaling Pathway WP4172	9/340	0.4759393525195222	1.0	0	0	1.0609454202522692	0.7877146754535862	NGFR;LAMB2;ITGA2;ITGA1;SPP1;FASLG;ITGAV;MET;CREB5
G1 to S cell cycle control WP45	2/64	0.47677230452669617	1.0	0	0	1.25250501002004	0.9277508154580869	CDKN2D;CCNA1
Cytokines and Inflammatory Response WP530	1/26	0.48177439669322825	1.0	0	0	1.5415446277169724	1.1257581796782758	IL11
Pathways Affected in Adenoid Cystic Carcinoma WP3651	2/65	0.4848972014536226	1.0	0	0	1.233235702173578	0.8926386511807349	CHEK2;MYBL1
Brain-Derived Neurotrophic Factor (BDNF) signaling pathway WP2380	4/144	0.48528644823419126	1.0	0	0	1.11333778668448	0.8049609746973296	NGFR;NCF1;SORT1;SPP1
Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932	8/303	0.4857424482499199	1.0	0	0	1.0582220546703969	0.7641175287055265	NGFR;LAMB2;ITGA2;ITGB2;SPP1;ITGAV;MET;CREB5
Eicosanoid Synthesis WP167	1/27	0.49472092704616494	1.0	0	0	1.4844503822459734	1.0446989670368623	ALOX5
Follicle Stimulating Hormone (FSH) signaling pathway WP2035	1/27	0.49472092704616494	1.0	0	0	1.4844503822459734	1.0446989670368623	PRKACA
Intraflagellar transport proteins binding to dynein WP4532	1/27	0.49472092704616494	1.0	0	0	1.4844503822459734	1.0446989670368623	WDR19
Nanoparticle-mediated activation of receptor signaling WP2643	1/28	0.5073446527319083	1.0	0	0	1.43143429716576	0.9713208100724187	ITGA1
Gastric Cancer Network 1 WP2361	1/29	0.5196536067270527	1.0	0	0	1.3820744938152165	0.9046960545734432	CCNA1
Lipid Metabolism Pathway WP3965	1/29	0.5196536067270527	1.0	0	0	1.3820744938152165	0.9046960545734432	PRKACA
MAPK Cascade WP422	1/29	0.5196536067270527	1.0	0	0	1.3820744938152165	0.9046960545734432	MAP2K6
Selective expression of chemokine receptors during T-cell polarization WP4494	1/29	0.5196536067270527	1.0	0	0	1.3820744938152165	0.9046960545734432	CCR4
Statin Pathway WP430	1/29	0.5196536067270527	1.0	0	0	1.3820744938152165	0.9046960545734432	LRP1
T-Cell Receptor and Co-stimulatory Signaling WP2583	1/29	0.5196536067270527	1.0	0	0	1.3820744938152165	0.9046960545734432	GSK3A
miRs in Muscle Cell Differentiation WP2012	1/29	0.5196536067270527	1.0	0	0	1.3820744938152165	0.9046960545734432	PRKACA
Extracellular vesicle-mediated signaling in recipient cells WP2870	1/30	0.531655622454183	1.0	0	0	1.3360053440213762	0.8440338349505794	MET
Inflammatory Response Pathway WP453	1/30	0.531655622454183	1.0	0	0	1.3360053440213762	0.8440338349505794	LAMB2
Matrix Metalloproteinases WP129	1/30	0.531655622454183	1.0	0	0	1.3360053440213762	0.8440338349505794	MMP19
Ethanol effects on histone modifications WP3996	1/31	0.5433583388350804	1.0	0	0	1.2929083974400413	0.7886563481965001	ALDH2
Wnt Signaling WP428	3/115	0.5500298433977507	1.0	0	0	1.045569399668903	0.625023342167288	FZD2;CSNK2A2;NKD1
Constitutive Androstane Receptor Pathway WP2875	1/32	0.5547692049322223	1.0	0	0	1.25250501002004	0.7379798330323151	SULT1A1
Monoamine Transport WP727	1/32	0.5547692049322223	1.0	0	0	1.25250501002004	0.7379798330323151	STX1A
Alpha 6 Beta 4 signaling pathway WP244	1/33	0.5658954848618294	1.0	0	0	1.2145503127467057	0.6914992087824988	LAMB2
Fluoropyrimidine Activity WP1601	1/33	0.5658954848618294	1.0	0	0	1.2145503127467057	0.6914992087824988	CDA
Monoamine GPCRs WP58	1/33	0.5658954848618294	1.0	0	0	1.2145503127467057	0.6914992087824988	HRH2
Prion disease pathway WP3995	1/33	0.5658954848618294	1.0	0	0	1.2145503127467057	0.6914992087824988	SPI1
Fatty Acid Beta Oxidation WP143	1/34	0.5767442622659661	1.0	0	0	1.1788282447247436	0.6487755869007844	CHKB
p38 MAPK Signaling Pathway WP400	1/34	0.5767442622659661	1.0	0	0	1.1788282447247436	0.6487755869007844	MAP2K6
Cell Cycle WP179	3/120	0.5789471346397347	1.0	0	0	1.0020040080160322	0.5476393889501465	CDKN2D;CCNA1;CHEK2
DNA IR-damage and cellular response via ATR WP4016	2/80	0.596856406413307	1.0	0	0	1.0020040080160322	0.5171129456825849	CHEK2;TP53BP1
Wnt Signaling in Kidney Disease WP4150	1/36	0.5976367686206209	1.0	0	0	1.11333778668448	0.5731152526311586	FZD2
Zinc homeostasis WP3529	1/36	0.5976367686206209	1.0	0	0	1.11333778668448	0.5731152526311586	SLC39A11
The effect of progerin on the involved genes in Hutchinson-Gilford Progeria Syndrome WP4320	1/37	0.607693802400194	1.0	0	0	1.0832475762335483	0.5395484356233516	MTA2
Type II interferon signaling (IFNG) WP619	1/37	0.607693802400194	1.0	0	0	1.0832475762335483	0.5395484356233516	SPI1
Signaling Pathways in Glioblastoma WP2261	2/82	0.6103297683136937	1.0	0	0	0.9775648858692996	0.4826783949317437	MET;MAP2K6
Alzheimers Disease WP2059	2/83	0.6169367397529046	1.0	0	0	0.9657869956781032	0.4664642915679145	LRP1;SNCA
Amyotrophic lateral sclerosis (ALS) WP2447	1/38	0.617499951558055	1.0	0	0	1.0547410610695074	0.5084656565008984	MAP2K6
Parkinsons Disease Pathway WP2371	1/38	0.617499951558055	1.0	0	0	1.0547410610695074	0.5084656565008984	SNCA
Apoptosis WP254	2/84	0.6234574058270773	1.0	0	0	0.95428953144384	0.4508777849292768	DFFB;FASLG
MicroRNAs in cardiomyocyte hypertrophy WP1544	2/84	0.6234574058270773	1.0	0	0	0.95428953144384	0.4508777849292768	FZD2;MAP2K6
G13 Signaling Pathway WP524	1/39	0.627061462527919	1.0	0	0	1.0276964184779815	0.4796369321136311	WAS
Ferroptosis WP4313	1/40	0.6363844264214737	1.0	0	0	1.0020040080160322	0.4528581705268795	SLC7A11
Glycogen Synthesis and Degradation WP500	1/40	0.6363844264214737	1.0	0	0	1.0020040080160322	0.4528581705268795	GSK3A
Angiopoietin Like Protein 8 Regulatory Pathway WP3915	3/132	0.6433911876346755	1.0	0	0	0.9109127345600292	0.4017146664500507	GSK3A;FBP1;MAP2K6
TGF-beta Signaling Pathway WP366	3/132	0.6433911876346755	1.0	0	0	0.9109127345600292	0.4017146664500507	ITGA2;MET;MAP2K6
Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433	1/41	0.6454747830319615	1.0	0	0	0.9775648858692996	0.42794773473722786	CARD9
Common Pathways Underlying Drug Addiction WP2636	1/42	0.6543383244988259	1.0	0	0	0.95428953144384	0.4047435304314916	PRKACA
TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036	1/42	0.6543383244988259	1.0	0	0	0.95428953144384	0.4047435304314916	TNFSF12
T-Cell antigen Receptor (TCR)  Signaling Pathway WP69	2/90	0.6607823296802989	1.0	0	0	0.8906702293475841	0.3690321068194072	WAS;SKAP1
Heart Development WP1591	1/44	0.6714074145685438	1.0	0	0	0.9109127345600292	0.3628886418772273	HEY1
Integrated Cancer Pathway WP1971	1/44	0.6714074145685438	1.0	0	0	0.9109127345600292	0.3628886418772273	CHEK2
Ectoderm Differentiation WP2858	3/138	0.6728926011406288	1.0	0	0	0.8713078330574192	0.3451856271931882	BCAS3;GAS2L1;SNCA
G Protein Signaling Pathways WP35	2/93	0.6783038044085001	1.0	0	0	0.8619389316266943	0.3345702176875032	AKAP7;PRKACA
Glycolysis and Gluconeogenesis WP534	1/45	0.6796238418937326	1.0	0	0	0.8906702293475841	0.3439909218923916	FBP1
Prostaglandin Synthesis and Regulation WP98	1/45	0.6796238418937326	1.0	0	0	0.8906702293475841	0.3439909218923916	ANXA6
Endoderm Differentiation WP2853	3/141	0.6869558761926731	1.0	0	0	0.8527693685242825	0.3202022902112281	HHEX;ATP8B2;TRERF1
Regulation of Microtubule Cytoskeleton WP2038	1/46	0.6876352184737552	1.0	0	0	0.8713078330574192	0.3263019842853477	PRKACA
Selenium Metabolism and Selenoproteins WP28	1/46	0.6876352184737552	1.0	0	0	0.8713078330574192	0.3263019842853477	SARS2
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534	1/47	0.6954466517190881	1.0	0	0	0.8527693685242825	0.3097266665191047	ITGB2
Differentiation Pathway WP2848	1/48	0.70306312169229	1.0	0	0	0.83500334001336	0.29417885952429185	IL11
Hepatitis C and Hepatocellular Carcinoma WP3646	1/49	0.7104894851601173	1.0	0	0	0.8179624555232914	0.27958049222211656	FASLG
IL-3 Signaling Pathway WP286	1/49	0.7104894851601173	1.0	0	0	0.8179624555232914	0.27958049222211656	PRKACA
Mesodermal Commitment Pathway WP2857	3/147	0.7137150435797103	1.0	0	0	0.8179624555232914	0.27587542017215044	ATP8B2;PRKACA;TRERF1
Calcium Regulation in the Cardiac Cell WP536	3/149	0.7222332497744723	1.0	0	0	0.8069830937041869	0.262598053798359	ANXA6;ARRB1;PRKACA
Regulation of Actin Cytoskeleton WP51	3/150	0.7264178168659076	1.0	0	0	0.8016032064128257	0.25621637224214777	GSN;ITGA1;WAS
Wnt Signaling Pathway and Pluripotency WP399	2/102	0.7264644479507639	1.0	0	0	0.7858854964831624	0.25114207491962226	FZD2;NKD1
Electron Transport Chain (OXPHOS system in mitochondria) WP111	2/103	0.7314211003301349	1.0	0	0	0.7782555402066268	0.24341181348985963	NDUFB1;SLC25A6
Toll-like Receptor Signaling Pathway WP75	2/103	0.7314211003301349	1.0	0	0	0.7782555402066268	0.24341181348985963	SPP1;MAP2K6
Copper homeostasis WP3286	1/52	0.7316747071553329	1.0	0	0	0.7707723138584862	0.2408041104693983	STEAP4
One carbon metabolism and related pathways WP3940	1/52	0.7316747071553329	1.0	0	0	0.7707723138584862	0.2408041104693983	CHKB
Wnt Signaling Pathway WP363	1/52	0.7316747071553329	1.0	0	0	0.7707723138584862	0.2408041104693983	GSK3A
Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864	1/53	0.7383868385846662	1.0	0	0	0.7562294400120997	0.22935487593120754	NQO1
Senescence and Autophagy in Cancer WP615	2/105	0.7411058353222701	1.0	0	0	0.7634316251550721	0.22873315101790864	GSN;ATG10
Breast cancer pathway WP4262	3/154	0.7426640052243462	1.0	0	0	0.7807823439085964	0.23229176553563394	FZD2;HEY1;CSNK2A2
IL-4 Signaling Pathway WP395	1/54	0.7449313935863037	1.0	0	0	0.7422251911229867	0.21855797074812172	FES
Interferon type I signaling pathways WP585	1/54	0.7449313935863037	1.0	0	0	0.7422251911229867	0.21855797074812172	MAP2K6
TGF-beta Receptor Signaling WP560	1/54	0.7449313935863037	1.0	0	0	0.7422251911229867	0.21855797074812172	SPP1
Nonalcoholic fatty liver disease WP4396	3/155	0.746603678064511	1.0	0	0	0.7757450384640249	0.22668882494900022	GSK3A;NDUFB1;FASLG
Cardiac Hypertrophic Response WP2795	1/55	0.7513125476348684	1.0	0	0	0.7287301876480233	0.20836840117723593	MAP2K6
Pathogenic Escherichia coli infection WP2272	1/55	0.7513125476348684	1.0	0	0	0.7287301876480233	0.20836840117723593	WAS
Thermogenesis WP4321	2/108	0.7550724738628684	1.0	0	0	0.7422251911229867	0.20852189005320892	PRKACA;CREB5
Mitochondrial complex I assembly model OXPHOS system WP4324	1/56	0.7575343725314059	1.0	0	0	0.71571714858288	0.1987448943236483	NDUFB1
Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706	3/158	0.7581342301037409	1.0	0	0	0.7610157022906573	0.2107213092877968	DLX2;KCNQ1;PRKACA
Insulin Signaling WP481	3/160	0.7655836255390477	1.0	0	0	0.751503006012024	0.20073909831277228	GSK3A;INPPL1;MAP2K6
Complement and Coagulation Cascades WP558	1/58	0.7695158178272834	1.0	0	0	0.6910372469076083	0.18104745348185977	CR1
GPCRs, Class A Rhodopsin-like WP455	5/257	0.7716488834260782	1.0	0	0	0.7797696560436047	0.20213629331163618	P2RY13;GPR15;HRH2;GPR75;CCR4
Kit receptor signaling pathway WP304	1/59	0.7752830853042475	1.0	0	0	0.6793247511973098	0.17290652149302896	BTK
MET in type 1 papillary renal cell carcinoma WP4205	1/59	0.7752830853042475	1.0	0	0	0.6793247511973098	0.17290652149302896	MET
Oxidative phosphorylation WP623	1/60	0.7809063226585379	1.0	0	0	0.6680026720106881	0.16519711537479384	NDUFB1
Notch Signaling Pathway WP61	1/61	0.7863891198039291	1.0	0	0	0.657051808535103	0.15789187929471432	HEY1
Oxidation by Cytochrome P450 WP43	1/61	0.7863891198039291	1.0	0	0	0.657051808535103	0.15789187929471432	CYP1A1
ESC Pluripotency Pathways WP3931	2/116	0.7891741420869729	1.0	0	0	0.6910372469076083	0.16361569351488306	FZD2;MAP2K6
Spinal Cord Injury WP2431	2/118	0.7970193640678442	1.0	0	0	0.6793247511973098	0.1541226889654096	NGFR;AIF1
AGE/RAGE pathway WP2324	1/66	0.8118160206220306	1.0	0	0	0.6072751563733528	0.12660565985377903	NCF1
Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680	1/66	0.8118160206220306	1.0	0	0	0.6072751563733528	0.12660565985377903	FZD2
Human Thyroid Stimulating Hormone (TSH) signaling pathway WP2032	1/66	0.8118160206220306	1.0	0	0	0.6072751563733528	0.12660565985377903	MAP2K6
Non-small cell lung cancer WP4255	1/66	0.8118160206220306	1.0	0	0	0.6072751563733528	0.12660565985377903	RASSF1
DNA Damage Response WP707	1/68	0.8211197204007441	1.0	0	0	0.5894141223623718	0.11616548243816698	CHEK2
AMP-activated Protein Kinase (AMPK) Signaling WP1403	1/69	0.8255979685294595	1.0	0	0	0.5808718887049461	0.11132255517230018	CCNA1
Parkin-Ubiquitin Proteasomal System pathway WP2359	1/70	0.8299643219162436	1.0	0	0	0.572573718866304	0.1067120324984155	SNCA
Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341	1/71	0.8342215710219	1.0	0	0	0.5645093002907223	0.10232083277541004	IFI27L2
miRNA Regulation of DNA Damage Response WP1530	1/71	0.8342215710219	1.0	0	0	0.5645093002907223	0.10232083277541004	CHEK2
Metapathway biotransformation Phase I and II WP702	3/183	0.8384557966204931	1.0	0	0	0.657051808535103	0.11576820284318716	SULT1A1;CYP1A1;FMO5
Chromosomal and microsatellite instability in colorectal cancer  WP4216	1/73	0.8424195720747036	1.0	0	0	0.5490432920635792	0.09414834311107505	MSH3
VEGFA-VEGFR2 Signaling Pathway WP3888	4/236	0.8435620251756762	1.0	0	0	0.6793247511973098	0.11556798110976747	NCF1;TNFRSF10C;ITGAV;MAP2K6
Peptide GPCRs WP24	1/74	0.8463655642939709	1.0	0	0	0.5416237881167741	0.09034496214788214	CCR4
Leptin signaling pathway WP2034	1/76	0.8539641476060756	1.0	0	0	0.5273705305347537	0.08325391192950704	GSK3A
Selenium Micronutrient Network WP15	1/86	0.8866867338848907	1.0	0	0	0.46604837582141023	0.05604862465843398	ALOX5
Integrated Breast Cancer Pathway WP1984	2/151	0.8937353095960248	1.0	0	0	0.5308630506045203	0.05964013957697764	GSK3A;CHEK2
Amino Acid metabolism WP3925	1/91	0.9001907994855396	1.0	0	0	0.4404413222048493	0.04631176141212195	P4HA2
GPCRs, Other WP117	1/91	0.9001907994855396	1.0	0	0	0.4404413222048493	0.04631176141212195	P2RY13
TNF alpha Signaling Pathway WP231	1/92	0.9026923740060074	1.0	0	0	0.4356539165287096	0.04459939648707088	MAP2K6
Myometrial Relaxation and Contraction Pathways WP289	2/156	0.9039538716882058	1.0	0	0	0.5138482092389908	0.0518868232801266	ARRB1;PRKACA
Corticotropin-releasing hormone signaling pathway WP2355	1/93	0.9051313712046625	1.0	0	0	0.43096946581334716	0.042956960917541025	ARRB1
Epithelial to mesenchymal transition in colorectal cancer WP4239	2/159	0.9096371549638503	1.0	0	0	0.5041529600080665	0.047748069620732414	FZD2;MAP2K6
DNA Damage Response (only ATM dependent) WP710	1/110	0.9383936227211765	1.0	0	0	0.36436509382401167	0.02316843781112707	FASLG
mRNA Processing WP411	1/126	0.9589784016902992	1.0	0	0	0.31809651048128	0.01332402139252831	CLASRP
Circadian rhythm related genes WP3594	2/201	0.9623870851708951	1.0	0	0	0.3988075653795152	0.01528969732906486	NGFR;ARNT2
Ciliary landscape WP4352	2/216	0.9727322380282003	1.0	0	0	0.37111259556149334	0.01025993721834995	EXOC4;CDH23
EGF/EGFR Signaling Pathway WP437	1/162	0.9835893230701859	1.0	0	0	0.24740839704099557	0.004093823115372884	INPPL1
